Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. - Wikidata - awgldk - TriplyDB

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

http://www.wikidata.org/entity/Q36409885

about

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice Stem-cell-based gene therapy for HIV infection Recent Advances in Lentiviral Vaccines for HIV-1 Infection Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis Animal Models for HIV Cure Research Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs Manipulation of the host protein acetylation network by human immunodeficiency virus type 1 Progress toward curing HIV infection with hematopoietic cell transplantation Redefining the viral reservoirs that prevent HIV-1 eradication Animal models in HIV cure research HIV-1 eradication strategies: design and assessment HIV-1 functional cure: will the dream come true?Developing Combined HIV Vaccine Strategies for a Functional Cure Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure Recent developments in human immunodeficiency virus-1 latency research Emerging strategies to deplete the HIV reservoir Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes Elimination of HIV-1-infected cells by broadly neutralizing antibodies HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell Targeting the Brain Reservoirs: Toward an HIV Cure Are T cells the only HIV-1 reservoir?Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents Achieving HIV-1 Control through RNA-Directed Gene Regulation Understanding HIV latency: the road to an HIV cure Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.Targeted cytotoxic therapy kills persisting HIV infected cells during ART Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency Recent Insights into the HIV/AIDS Pandemic.Barriers to HIV Cure.Latency reversal and viral clearance to cure HIV-1.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Developments in HIV-1 immunotherapy and therapeutic vaccination.When noise makes music: HIV reactivation with transcriptional noise enhancers.A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Tetherin/BST-2: Restriction Factor or Immunomodulator?A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.

P2860

Q21090483-22F31C7F-53D9-4B12-B0A5-79781A87C00B Q24607667-4C63712A-575E-4693-8897-1AD259385B6F Q26742169-DC12161C-C842-4098-AF67-B24CB1B9196E Q26746099-468B9F8B-3224-41CD-B4CE-5608E29B7EE8 Q26767476-9504E25C-392A-45C1-AACB-6E0D3E9A3A4D Q26781511-DCDF3E9D-8A88-4896-82A4-39E957F6D296 Q26795463-AAD3A8C2-3784-4DD6-BE05-9A36B3E9A4F5 Q26801269-3809EDF4-9561-49D5-A98A-8A44E23E052E Q26827255-61A5F77E-5926-4B60-B17D-63E8CB8EC081 Q26853069-6CA51E59-57CD-421E-B0EF-67F5CB3EEB1F Q26864933-0104D591-5D44-49A9-8B28-5394F178C36E Q26865803-2124E2BB-F66C-481B-97C9-640D2337CBC8 Q26998898-CB1B94CD-53C1-45B4-B3A7-674AE3906697 Q26999858-63930791-5BF2-4326-92A1-5CDAFA6E7843 Q27013114-221F6F6B-8F1D-4459-B542-4EFC85891807 Q27023877-812C1740-3F9D-4405-9062-CAFB4980BEC9 Q27312050-E90681C3-DEE3-4569-AC7D-16E07F953FF7 Q27316403-00FE2BC6-DF5E-40FB-B97B-1B078DF1F88D Q27324527-A4A8AD8E-C1E3-41FC-8BCD-3E96EBAA1E95 Q27329126-90266B4F-08CD-45A8-9218-F3684023DB6A Q27681313-C5D8AE96-6E86-4AC0-9A77-4C54A2D4F700 Q28075694-FE408613-567E-4E7D-8996-6FEE4F31B29E Q28078850-A0549D05-F8CA-4AE2-BE78-29064F9B16B2 Q28079455-71BB3197-66CA-4854-8C03-C748011916B6 Q28080090-16159167-B346-4E60-B2B8-05D33D579E14 Q28085296-D3FED1DC-F0F7-468E-B2C4-21B8FA1C8463 Q28537694-63E6362F-405F-4FEA-AA9F-353CF80353DD Q28538598-0F7ADAD1-FFF0-4A5C-AAE9-8DE247F06661 Q28541244-D6EE7E7C-6E51-470A-B40B-3A93834539B6 Q28546901-366FD8B3-211C-41C8-99B9-56439858B378 Q28728736-212CE435-C607-48BA-A75A-95C96FCF038E Q30235024-42BC81C0-DF35-466F-838D-A40600B92695 Q30245414-7EA8FF47-DFB1-420B-BAC8-2241EF80F7DD Q30248766-ECC76E71-F89B-4E87-9B1C-417FD86E18E8 Q30362489-DB35EF7D-AB7E-4263-8927-5E7F3206276D Q30364312-A289DF45-C270-4D94-8227-861F72E9D2BA Q30367371-DA486E78-508D-468C-ACB2-3FD7A0DC4C32 Q30385378-F9DE0224-C343-4403-9A06-6D9D24073782 Q30385433-EA1619BC-5619-4D74-B67E-5A3886C481F4 Q30934059-01E751F0-89D5-4937-AE3C-08057070C522

P2860

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

http://www.wikidata.org/entity/Q36409885

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@ast

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@en

type

label

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@ast

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@en

prefLabel

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@ast

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@en

P1433

Q36409885-67917FD6-8BF6-48DD-8A0B-C7065EAF98DC

P1476

Q36409885-6FDD2603-F3AE-42D8-8017-721E525EF91C

P2093

Q36409885-474792F1-88C3-493A-9192-9DD6EE78B807

Q36409885-811617D3-3798-49C3-9BAD-A42A77E8FF00

Q36409885-9DCA0D88-7F23-4828-B9C8-36B0F27DBECB

Q36409885-A3969712-1541-452D-A043-8F9599208825

Q36409885-C74857C5-AAA6-4342-8D65-84280516F45C

Q36409885-C7A2E6F9-6414-49D1-939F-3B468440C6D5

Q36409885-F272E40C-2D30-4D38-A3C6-6052304202DB

P2860

Q36409885-00AB1826-AEB7-4719-8877-DC59BCD19EF0

Q36409885-019F7F9B-862A-4B08-8C0F-B122C3EC0280

Q36409885-038CB1B8-4276-4BAD-8CC6-8028B114AC74

Q36409885-0828B13E-6E28-4372-99B5-93CC9E5E406C

Q36409885-0CBB6AC3-4E90-4697-858F-5647DAB83AB9

Q36409885-0E6B34C9-1D4E-41F5-A31A-CE5D3B338BD5

Q36409885-16C69E39-84CA-4BB3-89CE-D98C8B558C24

Q36409885-173CD370-14E8-4332-B34D-9C924187B479

Q36409885-1E1923F3-924F-4DEF-89BA-6251B20B4A8A

Q36409885-1F46AFAB-50C2-41C1-B8E2-21A8AB4275A1

P304

Q36409885-3274BE8E-3874-4B11-8124-8461F49166E5

P31

Q36409885-A5778616-74C9-4A79-9995-9AF5201AC93B

P356

Q36409885-15BA0E86-8549-4FF9-93AA-86A4F1DD59C6

P407

Q36409885-74774823-648C-4100-8819-89579896BAEE

P433

Q36409885-75FC5414-A96A-48B4-8EB3-7DE7023953B0

P478

Q36409885-DD8E54CE-0CC2-458D-AF39-4E63861628D6

P50

Q36409885-458F7895-22AC-4293-837A-A18909BC4203

Q36409885-8F31D8FA-AABF-4EF8-93EB-D26F49669FBA

Q36409885-A3664B0F-EF57-4707-9005-CE2043632A23

P577

Q36409885-D5FEBBE8-24A9-4464-A66C-92B7A2E33F17

P5875

Q36409885-1224B863-FE06-4CA0-B332-ED1ADE3DCCFD

P698

Q36409885-D87262C9-4C0E-4D6D-8023-2D77405E4EC1

P921

Q36409885-23981543-5660-43D9-BA18-6B4A44EE8C48

Q36409885-95A126B7-6144-4386-BBCE-B05D95227F33

P932

Q36409885-9D34B367-8FC7-4E6C-BD98-4DA3D83F6B1E

P356

J.IMMUNI.2012.01.014

P1433

P1476

Stimulation of HIV-1-specific ...... voir after virus reactivation.

@en

P2093

Hao Zhang

http://www.w3.org/2001/XMLSchema#string

Hung-Chih Yang

http://www.w3.org/2001/XMLSchema#string

Joel N Blankson

http://www.w3.org/2001/XMLSchema#string

Kai Deng

http://www.w3.org/2001/XMLSchema#string

Liang Shan

http://www.w3.org/2001/XMLSchema#string

Neeta S Shroff

http://www.w3.org/2001/XMLSchema#string

S Alireza Rabi

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

P304

491-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2012.01.014

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Christine M. Durand

Robert F. Siliciano

Joseph B Margolick

P577

2012-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221692281

http://www.w3.org/2001/XMLSchema#string

P698

22406268

http://www.w3.org/2001/XMLSchema#string

P921

P932

3501645

http://www.w3.org/2001/XMLSchema#string